BlueBird 6 took off aboard India’s LVM3 rocket on December 23 from the Satish Dhawan Space Center. With its next-generation ...
We recently published 10 Stocks Already Shocking 2026 With Massive Gains. AST SpaceMobile, Inc. (NASDAQ:ASTS) was one of the ...
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that O. James Sterling, has been appointed chief financial officer (CFO), effective June 10, 2024. Mr. Sterling ...
SOMERVILLE, Mass.--(BUSINESS WIRE)--Following the FDA approval of ZYNTEGLO® (betibeglogene autotemcel), also known as beti-cel, for the treatment of beta-thalassemia in adult and pediatric patients ...
Flying high as one of the world’s premier developers of gene therapies in early 2018, bluebird bio’s share price hit a dizzying $2,300 apiece. But seven years later—after failing to build a market for ...
After exploring a rival buyout offer worth 50% more than its first, bluebird bio is back where it started. Wednesday, the company said that it's sticking with the decision to sell to private equity ...
Bluebird Bio, a company that steered three gene therapies to FDA approval but struggled to commercialize them, has found the cash it needs to put those therapies on stronger financial footing by ...
bluebird will focus on expanding manufacturing capacity and improving the treatment experience for patients and providers SOMERVILLE, Mass., June 02, 2025--(BUSINESS WIRE)--bluebird bio (NASDAQ: BLUE) ...
Bluebird bio has shown cancer gene therapy vectors boost the efficacy of its CAR-T therapy in mice. The study assessed the effect of giving bluebird’s anti-EGFR CAR-T cells in combination with vectors ...
Prepaid cards are an easy way to manage your spending since you preload a set amount of cash on the card before you use it. Parents, therefore, can benefit from prepaid cards because they can help ...
Healthline has sole editorial control over this article. Potential uses for the products listed here are not health claims made by the manufacturers. The information in this article is intended to be ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...